Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster

PRINCETON, N.J. & SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)—- $BMY #CART–Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies….
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks